Editorial Comment
- PMID: 40145467
- PMCID: PMC12331213
- DOI: 10.1097/JU.0000000000004529
Editorial Comment
Comment on
-
Perceived Impact on Patient Routines/Responsibilities for Surgery and a Nonsurgical Primary Treatment Option in Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer: Findings From the ENVISION Phase 3 Trial.J Urol. 2025 Jul;214(1):18-31. doi: 10.1097/JU.0000000000004511. Epub 2025 Mar 6. J Urol. 2025. PMID: 40048558 Clinical Trial.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
